Cited by 193Probiotics and Fermented FoodsInflammatory Bowel DiseaseGut microbiota and health

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis

Zhang, Xiao-Feng, Guan, Xiao-Xian, Tang, Yu-Jun, Sun, Jin-Feng, Wang, Xiao-Kai, Wang, Wei-Dong, Fan, Jian-Ming·2021·European Journal of Nutrition

DOI 10.1007/s00394-021-02503-5

Open this paper in CoChat — free account

Abstract

Purpose Probiotics have been reported to be beneficial for inflammatory bowel disease (IBD), but the types, number of strains, dosage, and intervention time of probiotics used remain controversial. Furthermore, the changes of gut microbiota in IBD's patients are also intriguing. Thus, this meta-analysis was to explore the clinical effects and gut microbiota changes of using probiotics, prebiotics and synbiotics in IBD.Methods The search was performed in PubMed, Web of Science and the Cochrane library from inception to April 2020. Qualified randomized controlled trials were included. IBD's remission rate, disease activity index and recurrence rate were extracted and analyzed. Changes in the gut microbiota of patients with IBD are comprehensively described.Results Thirty-eight articles were included. Probiotics, prebiotics and synbiotics can induce/maintain IBD's remission and reduce ulcerative colitis (UC) disease activity index (RR = 1.13, 95% CI 1.02, 1.26, P < 0.05; SMD = 1.00, 95% CI 0.27, 1.73, P < 0.05). In subgroup analyses of IBD remission rate and UC disease activity index, we obtained some statistically significant results in some subgroup (P < 0.05). To some extent, probiotic supplements can increase the number of beneficial bacteria (especially Bifidobacteria) in the intestinal tract of patients with IBD.Conclusions Our results support the treatment of IBD (especially UC) with pro/pre/synbiotics, and synbiotics are more effective. Probiotic supplements that are based on Lactobacillus and Bifidobacterium or more than one strain are more likely to be beneficial for IBD remission. The dose of 10 10-10 12 CFU/day may be a reference range for using probiotics to relieve IBD.

Integrity signals

Registry

Crossref · 10.1007/s00394-021-02503-5

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., Abolhassani, H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30333-4 · Cited by 2,313
Mechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423
Probiotics, prebiotics and synbiotics- a review
Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1921-1 · Cited by 1,350
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
Rembacken, B., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,100

Show all 84 references

Sorted by citations

Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Cai, Z., Wang, S., & Li, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.765474 · Cited by 733
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
Inflammatory Bowel Diseases and Gut Microbiota
Haneishi, Y., Furuya, Y., Hasegawa, M., Picarelli, A., Rossi, M., & Miyamoto, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043817 · Cited by 261
Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
Martyniak, A., Medyńska-Przęczek, A., Wędrychowicz, A., Skoczeń, S., & Tomasik, P. (2021) · Biomolecules · doi:10.3390/biom11121903 · Cited by 264
Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications
Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
Liu, J., Di, B., & Xu, L. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.07.001 · Cited by 172
Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis
Gu, Z.-Y., Pei, W., Shen, Y., Wang, L., Zhu, J., Zhang, Y., Fan, S., Wu, Q., Li, L., & Zhang, Z. (2021) · Food & Function · doi:10.1039/d1fo02172a · Cited by 164
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology
Wang, M., Fu, R., Xu, D.-Q., Chen, Y., Yue, S., Zhang, S., & Tang, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116879 · Cited by 157
Self-citation
Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Xavier-Santos, D., Padilha, M., Fabiano, G. A., Vinderola, G., da Cruz, A. G., Sivieri, K., & Antunes, A. E. C. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.12.033 · Cited by 122
Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis
Sabatino, A. D., Santacroce, G., Rossi, C. M., Broglio, G., & Lenti, M. V. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03329-1 · Cited by 126
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Xiu, W., Peng, J., Cai, P., Xia, Y., Yi, C., Shang, A., Akanyibah, F. A., & Mao, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117302 · Cited by 114
The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
Kropp, C., Corf, K. L., Relizani, K., Tambosco, K., Martinez, C., Chain, F., Rawadi, G., Langella, P., Claus, S. P., & Martín, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90885-1 · Cited by 101
Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases
Caetano, M. A. F., & Castelucci, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.9985 · Cited by 92
Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
Li, M., Yang, L., Mu, C., Sun, Y., Gu, Y., Chen, D., Liu, T., & Cao, H. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.038 · Cited by 89
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 92
The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management
Ramos-López, O., Martínez‐Urbistondo, D., Vargas-Núñez, J. A., & Martínez, J. A. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00490-0 · Cited by 82
Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials.
Estevinho, M. M., Yuan, Y., Rodríguez‐Lago, I., Sousa‐Pimenta, M., Dias, C. C., Barreiro‐de Acosta, M., Jairath, V., & Magro, F. (2024) · United European gastroenterology journal · doi:10.1002/ueg2.12636 · Cited by 74
“Although the effect size varied across reviews, in most cases ( n = 14 7,9,22–24, 26,”
Research progress on the relationship between intestinal microecology and intestinal bowel disease
Fu, Q.-H., Song, T., Ma, X., & Cui, J. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12262 · Cited by 75
British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease
Lomer, M. C. E., Wilson, B., & Wall, C. L. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13054 · Cited by 70
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
Yang, X., Guo, H., & Zou, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00395-z · Cited by 82
Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier–Dependent Manner
Cao, R., Wu, X., Guo, H., Pan, X., Huang, R., Wang, G., & Liu, J. (2021) · Molecules · doi:10.3390/molecules26216604 · Cited by 69
Prevention and treatment of antibiotics-associated adverse effects through the use of probiotics: A review
Yang, S., Qiao, J., Zhang, M., Kwok, L., Matijašić, B. B., Zhang, H., & Zhang, W. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.006 · Cited by 73
Recent advances in prebiotics: Classification, mechanisms, and health applications
Ali, S., Hamayun, M., Siraj, M., Khan, S. A., Kim, H., & Lee, B. (2025) · Future Foods · doi:10.1016/j.fufo.2025.100680 · Cited by 72
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Wang, S., Ju, D., & Zeng, X. L. (2024) · Biomedicines · doi:10.3390/biomedicines12010194 · Cited by 63
Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome
Whelan, K., Alexander, M., Gaïani, C., Lunken, G., Holmes, A. J., Staudacher, H. M., Theis, S., & Marco, M. L. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01831-6 · Cited by 65
Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence
Dhopatkar, N., Keeler, J. L., Mutwalli, H., Whelan, K., Treasure, J. L., & Himmerich, H. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105959 · Cited by 62
Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake
Hamamah, S., Amin, A., Al-Kassir, A. L., Chuang, J., & Covașă, M. (2023) · Nutrients · doi:10.3390/nu15153365 · Cited by 56
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida, A., Nishino, K., Sakai, K., Owaki, Y., Noda, Y., & Imaeda, H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3317 · Cited by 52
Effect of early enteral nutrition combined with probiotics in patients with stroke: a meta-analysis of randomized controlled trials
Chen, X., Hu, Y., Yuan, X., Yang, J., & Li, K. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00986-3 · Cited by 53
Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms
Wilson, B., Eyice, Ö., Koumoutsos, I., Lomer, M. C. E., Irving, P. M., Lindsay, J. O., & Whelan, K. (2021) · Nutrients · doi:10.3390/nu13103598 · Cited by 53
Immunomodulatory Activity on Human Macrophages by Cell-Free Supernatants to Explore the Probiotic and Postbiotic Potential of Lactiplantibacillus plantarum Strains of Plant Origin
Rocchetti, M. T., Russo, P., Simone, N. D., Capozzi, V., Spano, G., & Fiocco, D. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10084-4 · Cited by 54
Progress in the investigation of the Firmicutes/Bacteroidetes ratio as a potential pathogenic factor in ulcerative colitis
Yin, Y., Yang, T., Tian, Z., Shi, C., Yan, C., Li, H., Du, Y., & Li, G. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001966 · Cited by 53
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives
Fan, Y., Liu, Y., Shao, C., Jiang, C., Wu, L., Xiao, J., & Tang, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125486 · Cited by 57
The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature
Vakadaris, G., Stefanis, C., Giorgi, E., Brouvalis, M., Voidarou, C. C., Kourkoutas, Y., Tsigalou, C., & Bezirtzoglou, E. (2023) · Biomedicines · doi:10.3390/biomedicines11020494 · Cited by 54
Recent progress on engineered micro/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease
Kan, L., Zheng, Z., Fu, W., Ma, Y., Wang, W., Qian, H., & Xu, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.014 · Cited by 51
Self-citation
Polyphenols-rich Portulaca oleracea L. (purslane) alleviates ulcerative colitis through restiring the intestinal barrier, gut microbiota and metabolites
Li, Z., Chu, T., Sun, X., Zhuang, S., Hou, D., Zhang, Z., Sun, J., Liu, Y., Li, J., & Bian, Y. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.142391 · Cited by 46
Self-citation
Diet and Microbiome-Directed Therapy 2.0 for IBD
Ananthakrishnan, A. N., Whelan, K., Allegretti, J. R., & Sokol, H. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.049 · Cited by 43
Dietary Lactobacillus johnsonii -derived extracellular vesicles ameliorate acute colitis by regulating gut microbiota and maintaining intestinal barrier homeostasis
Li, Z., Li, M., Fang, X., Yu, D., & Hu, X. (2024) · Food & Function · doi:10.1039/d4fo04194a · Cited by 42
Clostridium butyricum and Chitooligosaccharides in Synbiotic Combination Ameliorate Symptoms in a DSS-Induced Ulcerative Colitis Mouse Model by Modulating Gut Microbiota and Enhancing Intestinal Barrier Function
Huang, X., Hu, J., Zhang, H., Li, J., Zhu, X., Liu, Y., Liang, Y., & Mei, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04370-22 · Cited by 41
Gut microbiome‐targeted therapies as adjuvant treatments in inflammatory bowel diseases: a systematic review and network meta‐analysis
Zhang, T., Li, X., Li, J., Sun, F., & Duan, L. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16795 · Cited by 43
Protective Effects of Companilactobacillus crustorum MN047 against Dextran Sulfate Sodium-Induced Ulcerative Colitis: A Fecal Microbiota Transplantation Study
Wang, T., Shi, C., Wang, S., Zhang, Y., Wang, S., Ismael, M., Zhang, J., Wang, X., & Lü, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07316 · Cited by 40
Self-citation
Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders
Cerdó, T., García-Santos, J. A., Rodríguez-Pöhnlein, A., García-Ricobaraza, M., Nieto-Ruíz, A., García-Bermúdez, M., & Campoy, C. (2022) · Nutrients · doi:10.3390/nu14214691 · Cited by 46
The Networked Interaction between Probiotics and Intestine in Health and Disease: A Promising Success Story
Skoufou, M., Tsigalou, C., Vradelis, S., & Bezirtzoglou, E. (2024) · Microorganisms · doi:10.3390/microorganisms12010194 · Cited by 40
Ameba-inspired strategy enhances probiotic efficacy via prebound nutrient supply
Pan, C., Jiang, X., Wei, J., Liu, C., Zhang, M., Gao, C., Chen, R., Yang, C., Wang, B., Yu, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57071-7 · Cited by 45
Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses
Mahapatro, A., Bawna, F., Kumar, V., Daryagasht, A. A., Gupta, S., Raghuma, N., Moghdam, S. S., Kolla, A., Mahapatra, S. S., Sattari, N., et al. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.07.087 · Cited by 37
Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis
Lin, C., Zheng, Y., Lu, J., Zhang, H., Wang, G., & Chen, W. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121309 · Cited by 38
Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection
Jawhara, S. (2023) · Microorganisms · doi:10.3390/microorganisms11061556 · Cited by 43
Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota
CHIERICO, F. D., Trapani, V., Petito, V., Reddel, S., Pietropaolo, G., Graziani, C., Masi, L., Gasbarrini, A., Putignani, L., Scaldaferri, F., et al. (2021) · Nutrients · doi:10.3390/nu13124188 · Cited by 36
Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease
Ekstedt, N., Jamioł-Milc, D., & Pieczyńska, J. M. (2024) · Nutrients · doi:10.3390/nu16132092 · Cited by 34
Immunometabolism and microbial metabolites at the gut barrier: Lessons for therapeutic intervention in inflammatory bowel disease
Michaels, M., & Madsen, K. L. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.001 · Cited by 32
Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
Riggott, C., Ford, A. C., & Gracie, D. J. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18192 · Cited by 30
Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus
Vitetta, L., Gorgani, N. N., Vitetta, G., & Henson, J. D. (2023) · Biomolecules · doi:10.3390/biom13091307 · Cited by 33
Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
Silaghi, A. M., Constantin, V. D., Socea, B., Banu, P., Sandu, V., Andronache, L., Dumitriu, A. S., & Păunica, S. (2022) · Journal of Mind and Medical Sciences · doi:10.22543/7674.91.p5677 · Cited by 26
The Microbiome in Inflammatory Bowel Disease
Jauregui-Amezaga, A., & Smet, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164622 · Cited by 29
Recent advances in clinical practice: mastering the challenge—managing IBS symptoms in IBD
Wellens, J., Sabino, J., Vanuytsel, T., Tack, J. F., & Vermeire, S. (2024) · Gut · doi:10.1136/gutjnl-2024-333565 · Cited by 29
Systematically-designed mixtures outperform single fibers for gut microbiota support
Cantu-Jungles, T. M., Agamennone, V., van den Broek, T. J., Schuren, F. H. J., & Hamaker, B. R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2442521 · Cited by 28
Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission
Li, Z., Li, Z., Zhu, L., Dai, N., Sun, G., Peng, L., Wang, X., & Yang, Y. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.778542 · Cited by 25
Self-citation
Arabinoxylan and Pectin Metabolism in Crohn’s Disease Microbiota: An In Silico Study
Sabater, C., Calvete‐Torre, I., Ruíz, L., & Margollés, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137093 · Cited by 24
Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy
Ahmed, L. A., & Al‐Massri, K. F. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220222105004 · Cited by 23
Gastrointestinal microbiota-directed nutritional and therapeutic interventions for inflammatory bowel disease: opportunities and challenges
Paudel, D., Nair, D. V. T., Joseph, G., Castro, R., Tiwari, A. K., & Singh, V. (2023) · Gastroenterology report · doi:10.1093/gastro/goae033 · Cited by 24
The Interplay of Nutrition, the Gut Microbiota and Immunity and Its Contribution to Human Disease
Dawson, S. L., Todd, E., & Ward, A. C. (2025) · Biomedicines · doi:10.3390/biomedicines13020329 · Cited by 26
The Significant Role of Nutraceutical Compounds in Ulcerative Colitis Treatment
Maio, A. C. D., Basile, G., Iacopetta, D., Catalano, A. A., Ceramella, J., Cafaro, D., Saturnino, C., & Sinicropi, M. S. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867329666211227121321 · Cited by 23
The effect of oral synbiotics on the gut microbiota and inflammatory biomarkers in healthy adults: a systematic review and meta-analysis
Cosier, D., Lambert, K., Neale, E. P., Probst, Y., & Charlton, K. E. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae002 · Cited by 26
From pathogenic mechanisms to therapeutic perspectives: a review of gut microbiota and intestinal mucosal immunity in inflammatory bowel disease
Han, T., Zhang, Y., Zheng, G., & Guo, Y. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1704651 · Cited by 24
Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis
Hu, Y., Ye, Z., She, Y., Li, L., Wu, M., Qin, K., Li, Y., He, H., Hu, Z., Yang, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.844961 · Cited by 23
The Role of Prebiotics and Probiotics in Human Health: A Systematic Review with a Focus on Gut and Immune Health
Gill Jenkins, P. M. (2022) · Food & Nutrition Journal · doi:10.29011/2575-7091.100245 · Cited by 27
Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review
Chang, C., Yuan, X., Zhang, X., Chen, X., & Li, K. (2022) · Nutrients · doi:10.3390/nu14183726 · Cited by 22
Self-citation
Cross talk between the gut microbiome and host immune response in ulcerative colitis: nonpharmacological strategies to improve homeostasis
Bullard, B. M., VanderVeen, B. N., McDonald, S. J., Cardaci, T. D., & Murphy, E. A. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00210.2022 · Cited by 21
The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease
Li, S., Xu, K., Cheng, Y., Chen, L., Yi, A., Xiao, Z., Zhao, X., Chen, M., Tian, Y., Wei, M., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1188455 · Cited by 23
The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome
Rodríguez-Pastén, A., Pérez‐Hernández, N., Añorve‐Morga, J., Jiménez-Alvarado, R., Cariño‐Cortés, R., Sosa-Lozada, T., & Fernández‐Martínez, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137229 · Cited by 20
Synbiotics in the Management of Pediatric Gastrointestinal Disorders
Hojsak, I., Kolaček, S., Mihatsch, W., Mosca, A., Shamir, R., Szajewska, H., Vandenplas, Y., Working Group on Probiotics and Prebiotics of the European Society for Paediatric Gastroenterology, H. A. N., van den Akker, C. H. P., Canani, R. B., et al. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003568 · Cited by 20
Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease
Mohajeri, S., Moayedi, S., Mohajeri, S., Yadegar, A., & Haririan, I. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1045575 · Cited by 22
Feeding Broiler Chicks with Bacillus subtilis, Clostridium butyricum, and Enterococcus faecalis Mixture Improves Growth Performance and Regulates Cecal Microbiota
Dang, D. X., Zou, Q., Xu, Y., Cui, Y., Li, X., Xiao, Y., Wang, T., & Li, D. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-10029-3 · Cited by 20
Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin
Qian, G., Zang, H., Tang, J., Zhang, H., Yu, J., Jia, H., Zhang, X., & Zhou, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012541 · Cited by 20
Self-citation
Fecal microbiota and metabolites in the pathogenesis and precision medicine for inflammatory bowel disease
Ju, L., Suo, Z., Lin, J., & Liu, Z. (2024) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbae023 · Cited by 22
ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway
Li, J., Yan, Y., Fu, Y., Chen, Z., Yang, Y., Li, Y., Pan, J., Li, F., Zha, C., Miao, K., et al. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00603-8 · Cited by 22
Self-citation
Targeting gut microbiota dysbiosis in inflammatory bowel disease: a systematic review of current evidence
Farah, A., Paul, P., Khan, A. S., Sarkar, A., Laws, S., & Châari, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1435030 · Cited by 23
To Fiber or Not to Fiber: The Swinging Pendulum of Fiber Supplementation in Patients with Inflammatory Bowel Disease
Haskey, N., Gold, S. L., Faith, J. J., & Raman, M. (2023) · Nutrients · doi:10.3390/nu15051080 · Cited by 19
Comparative efficacy and tolerability of probiotic, prebiotic, and synbiotic formulations for adult patients with mild-moderate ulcerative colitis in an adjunctive therapy: A network meta-analysis
Zhou, S., Wang, M., Li, W., Zhang, Y., Zhao, T., Song, Q., & Cong, J. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.11.010 · Cited by 18
The Function of Probiotics and Prebiotics on Canine Intestinal Health and Their Evaluation Criteria
Xia, J., Cui, Y., Guo, Y., Liu, Y., Deng, B., & Han, S. (2024) · Microorganisms · doi:10.3390/microorganisms12061248 · Cited by 24
Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application
Zhang, J., Zhang, X., Cheng, X., Wang, S., Lv, Y., Xu, Z., & Wu, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1620079 · Cited by 17
Self-citation
Crosstalk Among Gut Microbiota, Microbial Metabolites, and Inflammatory Cytokines: Current Understanding and Future Directions
Wu, G., Wang, R., Wang, Y., Sun, S., Chen, J., & Zhang, Q. (2025) · Foods · doi:10.3390/foods14223836 · Cited by 17
Preventive and synbiotic effects of the soluble dietary fiber obtained from Lentinula edodes byproducts and Lactobacillus plantarum LP90 against dextran sulfate sodium‐induced colitis in mice
Xue, Z., Li, R., Liu, J., Zhou, J., Zhang, X., Zhang, T., Zhang, M., Yang, Y., & Chen, H. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12173 · Cited by 17
Self-citation
Should high-fiber diets be recommended for patients with inflammatory bowel disease?
Kuang, R., & Binion, D. G. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000810 · Cited by 17
Interaction between gut-heart axis in sepsis-induced cardiomyopathy
Zhou, Z.-K., Yu, M., Shou, S., Chai, Y., & Liu, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107806 · Cited by 18
Emerging concepts and shifting paradigms for understanding the microbial basis of inflammatory bowel diseases
Kennedy, M. S., & Chang, E. B. (2025) · Journal of Clinical Investigation · doi:10.1172/jci193969 · Cited by 16
Anthocyanins from purple corn affect gut microbiota and metabolome in inflammatory bowel disease patients under infliximab infusion: the SiCURA pilot study
Vacca, M., Sommella, E., Liso, M., Verna, G., Scarano, A., Sila, A., Curlo, M., Mastronardi, M., Petroni, K., Tonelli, C., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2023.9250036 · Cited by 17
Non-Dairy Fermented Probiotic Beverages: A Critical Review on the Production Techniques, Health Benefits, Safety Considerations and Market Trends
Abbasi, A., Sarabi‐Aghdam, V., Fathi, M., & Abbaszadeh, S. (2025) · Food Reviews International · doi:10.1080/87559129.2025.2550596 · Cited by 20
The effects of synbiotic supplementation on blood pressure and other maternal outcomes in pregnant mothers with mild preeclampsia: a triple-blinded randomized controlled trial
Movaghar, R., Abbasalizadeh, S., Vazifekhah, S., Farshbaf‐Khalili, A., & Shahnazi, M. (2024) · BMC Women s Health · doi:10.1186/s12905-024-02922-6 · Cited by 20
SARS-CoV-2 infection threatening intestinal health: A review of potential mechanisms and treatment strategies
Liu, S., Zhao, Y., Feng, X., & Xu, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2103090 · Cited by 16
Oral administration of nanozyme-armed probiotic Escherichia coli Nissle 1917 with ROS scavenging for inflammatory bowel disease therapy
Cui, T., Li, B., Lou, Z., Yang, K., Yan, K., Ding, D., & Ge, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.164949 · Cited by 14
Chinese consensus on prevention of colorectal neoplasia (2021, S hanghai)
Fang, J.-Y. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13079 · Cited by 14
Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review
El‐Saadony, M. T., Saad, A. M., Sitohy, M. Z., Alkafaas, S. S., Dladla, M., Ghosh, S., Mohammed, D. M., Ibrahim, E. H., Fahmy, M. A., Elkelish, A., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713426 · Cited by 15
Microbial Modulation in Inflammatory Bowel Diseases
Yu, J., & Cheon, J. H. (2022) · Immune Network · doi:10.4110/in.2022.22.e44 · Cited by 13
Recent Advances in Nanozyme‐Based Materials for Inflammatory Bowel Disease
Liu, C., Wang, Q., & Wu, Y. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300157 · Cited by 13
Urbanization gradient, diet, and gut microbiota in Sub-Saharan Africa: a systematic review
Paulo, L. S., Bwire, G. M., Klipstein‐Grobusch, K., Kamuhabwa, A. A. R., Kwesigabo, G., Chillo, P., Asselbergs, F. W., & Lenters, V. C. (2023) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1208166 · Cited by 15
Effect of Intestinal Microbiota Transplantation on Intestinal Flora and Inflammatory Factor Levels in Patients with Ulcerative Colitis
Wang, Z., Li, Y., & Sun, S. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s394614 · Cited by 12
From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease
Baldi, S., Sarikaya, D., Lotti, S., Cuffaro, F., Fink, D., Colombini, B., Sofi, F., & Amedei, A. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.05.012 · Cited by 13
Microbiota–Liver Diseases Interactions
Capparelli, R., Cuomo, P., Gentile, A., & Iannelli, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043883 · Cited by 12
Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects
Yan, X.-X., & Dong, W. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i1.47 · Cited by 11

Authors: Zhang, X.-F., Guan, X.-X., Tang, Y.-J., Sun, J.-F., Wang, X.-K., Wang, W.-D., & Fan, J.-M.
Affiliations: Zhengzhou University (CN)
ORCID: Zhang, Xiao-Feng
Guan, Xiao-Xian
Tang, Yu-Jun
Sun, Jin-Feng
Wang, Xiao-Kai
Wang, Wei-Dong
Fan, Jian-Ming
Venue: European Journal of Nutrition
Publisher: Springer Science and Business Media LLC
Published: 2021-02-08
Volume: 60
Issue: 5
Pages: 2855-2875
ISSN: 1436-6207 (ISSN-L)
1436-6215
DOI: 10.1007/s00394-021-02503-5
OpenAlex: W3126487719
Cited by: 193
References: 84
Citations by year: 2026: 26 · 2025: 38 · 2024: 46 · 2023: 35 · 2022: 35 · 2021: 13
FWCI: 2.91
Type: journal article
Language: en
Update notices: correction (2021-05-24)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: European Journal of Nutrition (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (31372453)
Science and Technology Department of Henan Province (152102310260)
Topics: Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: inflammatory bowel disease, probiotics, prebiotics, synbiotics, gut microbiota, ulcerative colitis, remission, disease activity index, recurrence, Bifidobacterium
MeSH terms: Gastrointestinal Microbiome, Humans, Inflammatory Bowel Diseases, Probiotics, Prebiotics, Synbiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks